PMID- 32814264 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 1879-1379 (Electronic) IS - 0022-3956 (Linking) VI - 129 DP - 2020 Oct TI - Staging of depressive disorders: Relevance of resistance to treatment and residual symptoms. PG - 234-240 LID - S0022-3956(20)30887-6 [pii] LID - 10.1016/j.jpsychires.2020.07.022 [doi] AB - BACKGROUND: Clinical staging model for depression helps to better define the clinical situation of patients. The objectives of this study are: to correlate the Hetrick's staging model of depression with the severity of depression, associated disability, and resistance to treatment in the established disease stages and to test the modification introduced by our group consisting in the introduction of a substage for recurrence from a previous episode that was stabilized with a complete remission. METHODS: A Cross-sectional study with 133 adult subjects having a current and primary diagnosis of Depressive disorder was developed. Patients were classified according to the model and assessed with: 17-item Hamilton Depression Scale (HAM-D), Clinical Global Impression (CGI); Global Assessment of Function (GAF); Maudsley Staging Method for treatment resistance (MSM) and Sheeham Disability Schedule (SDS). RESULTS: The variable that best contributes to the differentiation between clinical stages, in established Depression, is resistance to treatment evaluated by the MSM. Correlations between MSM and the clinical stages were statistically significant between most pairs of stages. Finally, we showed preliminary data in order to prove that a differential sub-stage for recurrent depression with and without inter-episodic remission in the current heuristic models could be a possible stage for better define depression staging model. CONCLUSIONS: Resistance to treatment should be included in the definition of clinical stages in established depression. Despite the difficulty of establishing a valid model for the staging of depression, it can certainly add great value to diagnosis, therapeutic interventions and clinical research. CI - Copyright (c) 2020 Elsevier Ltd. All rights reserved. FAU - Reneses, Blanca AU - Reneses B AD - Instituto de Psiquiatria y Salud Mental, Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain. Electronic address: blanca@reneses.es. FAU - Aguera-Ortiz, Luis AU - Aguera-Ortiz L AD - Servicio de Psiquiatria, Instituto de Investigacion i+12, Hospital Universitario 12 de Octubre, Madrid, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain. Electronic address: Luis@aguera.es. FAU - Sevilla-Llewellyn-Jones, Julia AU - Sevilla-Llewellyn-Jones J AD - Instituto de Psiquiatria y Salud Mental, Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: julia.sevilla@salud.madrid.org. FAU - Carrillo, Antonio AU - Carrillo A AD - Instituto de Psiquiatria y Salud Mental, Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: acargo@telefonica.net. FAU - Argudo, Isabel AU - Argudo I AD - Instituto de Psiquiatria y Salud Mental, Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: isabelmaria.argudo@salud.madrid.org. FAU - Regatero, Maria Jose AU - Regatero MJ AD - Instituto de Psiquiatria y Salud Mental, Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: mjose.regatero@salud.madrid.org. FAU - Lopez-Mico, Cristina AU - Lopez-Mico C AD - Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: cristina.lopez.mico@gmail.com. FAU - Fuentes, Manuel AU - Fuentes M AD - Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: mfuentesferrer@gmail.com. FAU - Palomo, Tomas AU - Palomo T AD - Facultad de Medicina, Universidad Complutense de Madrid, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Instituto de Investigacion (IdISSC), Hospital Clinico San Carlos, Madrid, Spain. Electronic address: tomaspalomo@med.ucm.es. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200722 PL - England TA - J Psychiatr Res JT - Journal of psychiatric research JID - 0376331 SB - IM MH - Adult MH - Cross-Sectional Studies MH - *Depressive Disorder, Major MH - Homosexuality, Male MH - Humans MH - Male MH - Psychiatric Status Rating Scales MH - Remission Induction MH - *Sexual and Gender Minorities MH - Treatment Outcome OTO - NOTNLM OT - Clinical staging OT - Depressive disorders OT - Major depression OT - Treatment resistance EDAT- 2020/08/20 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/08/20 06:00 PHST- 2020/03/25 00:00 [received] PHST- 2020/07/17 00:00 [revised] PHST- 2020/07/17 00:00 [accepted] PHST- 2020/08/20 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2020/08/20 06:00 [entrez] AID - S0022-3956(20)30887-6 [pii] AID - 10.1016/j.jpsychires.2020.07.022 [doi] PST - ppublish SO - J Psychiatr Res. 2020 Oct;129:234-240. doi: 10.1016/j.jpsychires.2020.07.022. Epub 2020 Jul 22.